Searched for: in-biosketch:true
person:gudesm01
Multiple Sclerosis, Ocrelizumab and Cognition: 2-year Multi-Domain Cognitive Stability [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Bumstead, B.; Buhse, M.; Zarif, M.; Gudesblatt, M.
ISI:000796572500115
ISSN: 1352-4585
CID: 5342962
Cognitive Function in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate: 3-Year Longitudinal Analysis [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Bumstead, B.; Buhse, M.; Zarif, M.; Scott, N.; Mendoza, J. P.; Gudesblatt, M.
ISI:000796572500338
ISSN: 1352-4585
CID: 5342982
Multiple Sclerosis, Cognitive Function and Shared Decision Making Preference: A Process With a Problem [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Teng, E.; Bumstead, B.; Buhse, M.; Zarif, M.; Gudesblatt, M.
ISI:000796572500414
ISSN: 1352-4585
CID: 5342992
Disease Modifying Therapy Choice in People with Multiple Sclerosis in The Era of Covid: Characterizing Outcomes in Patients who Switched from anti-CD20 Therapies to Diroximel Fumarate [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Teng, E.; Bumstead, B.; Buhse, M.; Zarif, M.; Scott, N.; Gocke, A.; Mendoza, J. P.; Gudesblatt, M.
ISI:000796572500159
ISSN: 1352-4585
CID: 5342972
Visual evoked potential latency predicts cognitive function in people with multiple sclerosis
Covey, Thomas J; Golan, Daniel; Doniger, Glen M; Sergott, Robert; Zarif, Myassar; Srinivasan, Jared; Bumstead, Barbara; Wilken, Jeffrey; Buhse, Marijean; Mebrahtu, Samson; Gudesblatt, Mark
Prior studies have reported an association between visual evoked potentials (VEPs) and cognitive performance in people with multiple sclerosis (PwMS), but the specific mechanisms that account for this relationship remain unclear. We examined the relationship between VEP latency and cognitive performance in a large sample of PwMS, hypothesizing that VEP latency indexes not only visual system functioning but also general neural efficiency. Standardized performance index scores were obtained for the domains of memory, executive function, visual-spatial processing, verbal function, attention, information processing speed, and motor skills, as well as global cognitive performance (NeuroTrax battery). VEP P100 component latency was obtained using a standard checkerboard pattern-reversal paradigm. Prolonged VEP latency was significantly associated with poorer performance in multiple cognitive domains, and with the number of cognitive domains in which performance was ≥ 1 SD below the normative mean. Relationships between VEP latency and cognitive performance were significant for information processing speed, executive function, attention, motor skills, and global cognitive performance after controlling for disease duration, visual acuity, and inter-ocular latency differences. This study provides evidence that VEP latency delays index general neural inefficiency that is associated with cognitive disturbances in PwMS.
PMID: 33870445
ISSN: 1432-1459
CID: 5342292
Multiple Sclerosis and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability [Meeting Abstract]
Kaczmarek, O.; Petroski, J.; Zodiatis, E.; Bumstead, B.; Buhse, M.; Zarif, M.; Golan, D.; Wilken, J.; Gudesblatt, M.
ISI:000669008200236
ISSN: 1352-4585
CID: 5342842
Multiple sclerosis, medication management, health literacy and accumulative cognitive impairment: is perception sufficient for performance? [Meeting Abstract]
Sethi, A.; Kaczmarek, O.; Petroski, J.; Bumstead, B.; Buhse, M.; Zarif, M.; Wilken, J.; Golan, D.; Krieger, S.; Doniger, G.; Gudesblatt, M.
ISI:000706771301102
ISSN: 1352-4585
CID: 5342912
Multiple sclerosis and the presence of unrecognized immune deficiencies: a cross sectional analysis [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Teng, E.; Kodym, C.; Bumstead, B.; Buhse, M.; Zarif, M.; Gudesblatt, M.
ISI:000706771301195
ISSN: 1352-4585
CID: 5342922
Meaning and purpose for people with multiple sclerosis: quality of life reflects more than apparent physical ability [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Malone, E.; Doshi, M.; Mardonov, J.; Bumstead, B.; Buhse, M.; Zarif, M.; Wilken, J.; Gudesblatt, M.
ISI:000706771301085
ISSN: 1352-4585
CID: 5342902
Efficacy and Safety Outcomes After Transition From Glatiramer Acetate to Diroximel Fumarate: Results From the Phase 3 EVOLVE-MS-1 Study [Meeting Abstract]
Wray, S.; Wundes, A.; Arnold, D. L.; Singer, B. A.; Bowen, J. D.; Hunter, S. F.; Gudesblatt, M.; Chen, H.; Lyons, J.; Melikov, M.; Mendoza, J. P.; Messer, J.; Naismith, R. T.
ISI:000669008200077
ISSN: 1352-4585
CID: 5342832